637 related articles for article (PubMed ID: 27843006)
61. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer.
Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961
[TBL] [Abstract][Full Text] [Related]
62. Preoperative Axillary Ultrasound in the Selection of Patients With a Heavy Axillary Tumor Burden in Early-Stage Breast Cancer: What Leads to False-Positive Results?
Zhu Y; Zhou W; Jia XH; Huang O; Zhan WW
J Ultrasound Med; 2018 Jun; 37(6):1357-1365. PubMed ID: 29424451
[TBL] [Abstract][Full Text] [Related]
63. Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI.
Barentsz MW; Taviani V; Chang JM; Ikeda DM; Miyake KK; Banerjee S; van den Bosch MA; Hargreaves BA; Daniel BL
J Magn Reson Imaging; 2015 Dec; 42(6):1656-65. PubMed ID: 25914178
[TBL] [Abstract][Full Text] [Related]
64. Differentiating axillary lymph node metastasis in invasive breast cancer patients: A comparison of radiomic signatures from multiparametric breast MR sequences.
Chai R; Ma H; Xu M; Arefan D; Cui X; Liu Y; Zhang L; Wu S; Xu K
J Magn Reson Imaging; 2019 Oct; 50(4):1125-1132. PubMed ID: 30848041
[TBL] [Abstract][Full Text] [Related]
65. Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening.
Kang JW; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Breast Cancer Res Treat; 2017 Aug; 165(1):119-128. PubMed ID: 28577079
[TBL] [Abstract][Full Text] [Related]
66. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
67. Effectiveness of diffusion-weighted imaging in predicting cervical lymph node metastasis in head and neck malignancies.
Zhou Y; Yu T; Rui X; Jin T; Huang Z; Huang Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jan; 131(1):122-129.e2. PubMed ID: 32807714
[TBL] [Abstract][Full Text] [Related]
68. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer.
Yasui O; Sato M; Kamada A
Tohoku J Exp Med; 2009 Jul; 218(3):177-83. PubMed ID: 19561387
[TBL] [Abstract][Full Text] [Related]
69. Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.
Ha SM; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
Acta Radiol; 2017 Oct; 58(10):1198-1205. PubMed ID: 28350255
[TBL] [Abstract][Full Text] [Related]
70. Diffusion-Weighted Magnetic Resonance Imaging of 103 Patients with Rectal Adenocarcinoma Identifies the Apparent Diffusion Coefficient as an Imaging Marker for Tumor Invasion and Regional Lymph Node Involvement.
Kargol J; Rudnicki W; Kenig J; Filipowska J; Kaznowska E; Kluz T; Guz W; Łuczyńska E
Med Sci Monit; 2021 Dec; 27():e934941. PubMed ID: 34871292
[TBL] [Abstract][Full Text] [Related]
71. Meta analysis of lymph node metastasis of breast cancer patients: Clinical value of DWI and ADC value.
Xing H; Song CL; Li WJ
Eur J Radiol; 2016 Jun; 85(6):1132-7. PubMed ID: 27161063
[TBL] [Abstract][Full Text] [Related]
72. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
[TBL] [Abstract][Full Text] [Related]
73. Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
Woo S; Kim SY; Cho JY; Kim SH
Radiol Med; 2018 Mar; 123(3):209-216. PubMed ID: 29058233
[TBL] [Abstract][Full Text] [Related]
74. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Wahl RL; Siegel BA; Coleman RE; Gatsonis CG;
J Clin Oncol; 2004 Jan; 22(2):277-85. PubMed ID: 14722036
[TBL] [Abstract][Full Text] [Related]
75. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
[TBL] [Abstract][Full Text] [Related]
76. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
[TBL] [Abstract][Full Text] [Related]
77. [Combined T2-weighted and diffusion-weighted MR imaging for staging of rectal cancers].
Zhang CD; Zhang HM; Meng YK; Ye F; Jiang J; Ouyang H; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):46-51. PubMed ID: 29365417
[No Abstract] [Full Text] [Related]
78. Diffusion tensor imaging and diffusion-weighted imaging on axillary lymph node status in breast cancer patients.
Kurt N; Binboga Kurt B; Gulsaran U; Uslu B; Celik AO; Sut N; Tastekin E; Karabulut D; Tuncbilek N
Diagn Interv Radiol; 2022 Jul; 28(4):329-336. PubMed ID: 35950277
[TBL] [Abstract][Full Text] [Related]
79. Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer.
Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Kuginuki Y; Taniguchi M; Ueda Y; Sakuma T
Ann Surg Oncol; 2013 May; 20(5):1676-83. PubMed ID: 23242821
[TBL] [Abstract][Full Text] [Related]
80. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study.
Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J
Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
